Epigenetic silencing of MHC2TA transcription in cancer.

Biochem Pharmacol

Division of Molecular Biology, Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands.

Published: November 2006

Lack of expression of major histocompatibility complex (MHC) molecules of both classes is frequently noted on tumour cells . It is thought that in this way tumour cells escape immunosurveillance. The genes encoding both classes of MHC molecules are localized on the distal part of chromosome 6 (6p21.3). The class II transactivator (CIITA), encoded by the MHC2TA gene, is essential for transcriptional activation of all MHC-II genes, while it has a helper function in the transcriptional regulation of MHC-I genes (with the exception of human leukocyte antigen (HLA)-G) and of the gene encoding beta2-microglobulin (beta2m) . Here we discuss our current knowledge on the expression characteristics of MHC2TA and argue for an important role of epigenetic factors and mechanisms in the transcriptional silencing of MHC2TA in cancer cells.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcp.2006.06.034DOI Listing

Publication Analysis

Top Keywords

silencing mhc2ta
8
mhc molecules
8
tumour cells
8
epigenetic silencing
4
mhc2ta
4
mhc2ta transcription
4
transcription cancer
4
cancer lack
4
lack expression
4
expression major
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!